Our Pricing

Get Wegovy: UK Prescription Weight Loss Treatment

Published on: June 03, 2026

Looking to get Wegovy UK prescription weight loss treatment through a trusted online pharmacy? At Cured Pharmacy, you can access genuine UK-licensed Wegovy (semaglutide) from £79.00, with a free clinical consultation completed in under 3 minutes by our UK-registered prescribers. We offer transparent upfront pricing, 100% discreet packaging, and next-day delivery across the UK.

How to Get Wegovy UK Prescription Online

Wegovy is a prescription-only medication in the UK, regulated by the MHRA and dispensed only after clinical assessment by a registered prescriber. At Cured Pharmacy, our streamlined process allows you to complete your online consultation in under 3 minutes, with prescriptions reviewed by our UK clinical team led by superintendent pharmacist Tarun Kumar (GPhC 2233073).

The consultation assesses your medical history, current medications, weight loss goals, and suitability for semaglutide therapy. If approved, your prescription is issued electronically and your Wegovy pen is dispensed from our GPhC-registered pharmacy (9012511) for discreet next-day delivery. All patients must meet NICE eligibility criteria, which typically include a BMI of 30 or above, or 27 with weight-related health conditions [1].

Unlike high-street consultations that may require multiple appointments, our online service provides clinical decisions within hours, allowing you to start treatment quickly whilst maintaining the same regulatory standards as traditional pharmacy services.

How Wegovy Works for Weight Loss

Wegovy contains semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist that mimics a natural hormone your body produces after eating. This medication works through three primary mechanisms: slowing gastric emptying to prolong feelings of fullness, reducing appetite signals in the brain, and improving blood sugar regulation [2].

In the landmark STEP 1 clinical trial, participants using Wegovy achieved an average body weight reduction of 14.9% over 68 weeks, compared to 2.4% with placebo [2]. Importantly, 83.5% of patients on semaglutide lost at least 5% of their body weight, and 66.1% lost 10% or more — results that positioned Wegovy as one of the most effective pharmaceutical weight loss interventions available in the UK [2].

The medication is administered as a once-weekly subcutaneous injection, starting at a low dose of 0.25mg and gradually increasing over 16-20 weeks to the maintenance dose of 2.4mg. This titration schedule, overseen by your UK prescriber, minimises gastrointestinal side effects whilst optimising therapeutic benefit [3].

Expected Timeline and Results

Most patients begin noticing reduced appetite within the first 2-4 weeks of treatment, with measurable weight loss typically evident by week 8. Clinical trials demonstrated that the majority of weight loss occurs within the first 60 weeks of continuous treatment, with patients maintaining results when combined with lifestyle modifications [2].

Your prescriber will schedule regular reviews to monitor progress, adjust dosing if needed, and assess whether continued treatment remains clinically appropriate. Wegovy is not a short-term solution but rather a long-term weight management tool used alongside dietary changes and increased physical activity.

Wegovy Pricing and What's Included

At Cured Pharmacy, Wegovy starts from £79.00 per pen, with transparent pricing displayed before you begin your consultation. This represents competitive UK pricing compared to typical market rates, with our lowest price guarantee ensuring you receive genuine UK-licensed medication without hidden fees.

Your Wegovy prescription includes the pre-filled injection pen with four single-use needles, full patient information leaflet, and access to our UK pharmacy team for ongoing support. We provide detailed injection technique guidance and can arrange follow-up consultations as your treatment progresses through the dose escalation schedule.

Many patients ask about long-term costs: because Wegovy requires gradual dose increases, your monthly expenditure will vary during the titration phase. Our clinical team provides clear cost projections during your consultation, allowing you to plan your weight loss journey with full financial transparency. Unlike some online services, we never require subscription commitments — you order only when clinically appropriate and financially ready.

Wegovy Eligibility and Who Can Use It

NICE guidelines specify that Wegovy may be prescribed to adults with a BMI of 30 kg/m² or greater, or 27 kg/m² or greater with at least one weight-related comorbidity such as hypertension, type 2 diabetes, dyslipidaemia, obstructive sleep apnoea, or cardiovascular disease [1]. Your UK prescriber will calculate your BMI during the online consultation and assess your medical history against these criteria.

Wegovy is not suitable for everyone. Contraindications include personal or family history of medullary thyroid carcinoma, multiple endocrine neoplasia syndrome type 2, pregnancy, breastfeeding, or severe gastrointestinal disease [3]. Patients with type 1 diabetes or diabetic ketoacidosis should not use Wegovy, and caution is required for those with renal impairment or history of pancreatitis.

Our clinical assessment specifically evaluates these factors, along with current medications that may interact with semaglutide. If Wegovy is not clinically appropriate for you, our prescribers may suggest alternative weight loss treatments available through Cured Pharmacy, ensuring you receive personalised recommendations based on your individual health profile.

Age and Special Populations

Wegovy is licensed for adults aged 18 years and over. It has not been studied extensively in patients over 75 years, and use in this population requires careful clinical consideration. Adolescents aged 12-17 may be considered in specialist settings, though this falls outside typical online pharmacy prescribing scope and would require paediatric endocrinology input.

Women of childbearing potential should use effective contraception during treatment and discontinue Wegovy at least 2 months before a planned pregnancy due to the medication's long half-life [3]. If you become pregnant whilst using Wegovy, stop treatment immediately and contact your prescriber.

Common Side Effects and How to Manage Them

The most frequently reported side effects of Wegovy are gastrointestinal: nausea (44% of patients), diarrhoea (30%), vomiting (24%), constipation (24%), and abdominal pain (20%) in clinical trials [2]. These effects are typically mild to moderate, most common during dose escalation, and tend to diminish as your body adapts to the medication.

To minimise gastrointestinal symptoms, eat smaller, more frequent meals, avoid high-fat foods, stay well-hydrated, and inject Wegovy at a consistent time each week. If nausea persists, your prescriber may slow the dose escalation schedule or recommend anti-nausea strategies. Severe or persistent vomiting requires immediate medical attention due to dehydration risk.

Rare but serious side effects include pancreatitis (persistent severe abdominal pain radiating to the back), gallbladder problems, hypoglycaemia in patients taking other diabetes medications, increased heart rate, and acute kidney injury secondary to dehydration [3]. Our patient information materials detail warning signs, and our pharmacy team remains available on (+44) 116 4646009 should you have concerns during treatment.

When to Stop Treatment and Seek Medical Advice

Discontinue Wegovy and contact a healthcare professional immediately if you experience symptoms of pancreatitis (severe upper abdominal pain, nausea, vomiting), signs of thyroid tumours (lump in neck, hoarseness, difficulty swallowing), severe allergic reactions, or significant changes in mood or suicidal thoughts [3].

Your prescriber will also review treatment continuation based on efficacy: NICE recommends stopping Wegovy if you have not lost at least 5% of your initial body weight after 6 months at the maintenance dose, as continued use is unlikely to provide meaningful clinical benefit [1].

Why Choose Cured Pharmacy for Your Wegovy Prescription

As a GPhC-registered online pharmacy (9012511), Cured Pharmacy operates under the same regulatory standards as high-street pharmacies, with the added convenience of online consultations and discreet home delivery. Our superintendent pharmacist Tarun Kumar (GPhC 2233073) oversees all clinical services, ensuring every prescription meets UK pharmaceutical standards.

We provide transparent upfront pricing — you see the exact cost of Wegovy (from £79.00) before completing your consultation, with no hidden fees or mandatory subscription models. Our UK-registered clinical team reviews consultations individually, rejecting applications where treatment would be clinically inappropriate rather than prioritising sales over patient safety.

Every Wegovy pen dispensed by Cured Pharmacy is genuine UK-licensed medication sourced through regulated pharmaceutical wholesalers, never grey-market imports. We provide 100% discreet packaging with no external branding, next-day delivery options, and ongoing clinical support throughout your weight loss journey. Our lowest price guarantee means you receive competitive UK pricing without compromising on pharmaceutical quality or clinical oversight.

Scientific References

1. National Institute for Health and Care Excellence. (2023). Semaglutide for managing overweight and obesity [TA875]. NICE. https://www.nice.org.uk/guidance/ta875 [accessed 13 August 2026]
2. Wilding, J. P. H., et al. (2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine, 384(11), 989–1002. https://doi.org/10.1056/NEJMoa2032183 [accessed 13 August 2026]
3. Electronic Medicines Compendium. (2023). Wegovy 2.4 mg solution for injection in pre-filled pen – Summary of Product Characteristics. Novo Nordisk Limited. https://www.medicines.org.uk/emc/product/13799 [accessed 13 August 2026]
4. NHS. (2026). Tirzepatide: a medicine to manage type 2 diabetes and treat obesity. https://www.nhs.uk/medicines/tirzepatide/ Accessed 13 August 2026.
5. NHS. (2026). Overweight and obesity in adults. https://www.nhs.uk/conditions/overweight-and-obesity/ Accessed 13 August 2026.
6. NHS England. (2026). Weight management injections. https://www.england.nhs.uk/ourwork/prevention/obesity/medicines-for-obesity/weight-management-injections/ Accessed 13 August 2026.

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication. Wegovy is a prescription-only medication and may not be suitable for everyone. Individual results may vary.